Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary Disease

NCT06627751 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Extramedullary Disease in Multiple Myeloma
Recurrent Multiple Myeloma
Refractory Multiple Myeloma

Interventions

BIOLOGICAL: Mezigdomide
DRUG: Carfilzomib
DRUG: Dexamethasone
PROCEDURE: Echocardiography
PROCEDURE: Positron Emission Tomography
PROCEDURE: Computed Tomography
PROCEDURE: Computed Tomography Assisted Biopsy
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Biospecimen Collection

Sponsor

Roswell Park Cancer Institute